# Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Adolescents

> **NCT01249001** · PHASE2 · TERMINATED · sponsor: **The Hospital for Sick Children** · enrollment: 4 (actual)

## Conditions studied

- Nausea
- Vomiting
- Chemotherapy

## Interventions

- **DRUG:** Oral Aprepitant
- **DRUG:** Aprepitant

## Key facts

- **NCT ID:** NCT01249001
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-10
- **Primary completion:** 2016-09-28
- **Final completion:** 2016-09-28
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** lack of eligible participants to enrol
- **Last updated:** 2017-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01249001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01249001, "Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Adolescents". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01249001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*